Jennifer Jarrett

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Garrett Winslow, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jennifer Jarrett

Form 4 holding Chief Operating Officer

Arcus Biosciences, Inc.

Security class
Stock Option (right to buy)
Shares / value
126,000
Estimated value
$98,923
Report date
23 Jan 2026
Price
$1.23
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Former Director

Surrozen, Inc./DE

Security class
Common Stock
Shares / value
30,000
Estimated value
$11,400
Report date
11 Aug 2021
Price
$0.3800
Ownership
Direct
Form 4 holding Director, President and CEO, Director

Damora Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
1,500,000
Estimated value
Report date
30 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ARENA PHARMACEUTICALS INC

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
11 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Radius Health, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
15 Aug 2022
Price
$4.16
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Former Director

Surrozen, Inc./DE

Security class
Class B Ordinary Shares
Shares / value
0
Estimated value
Report date
11 Aug 2021
Price
Ownership
Direct
Underlying class
Class A Ordinary Shares
Underlying amount

Insider Reports Filed by Jennifer Jarrett

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .